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Materials and Methods: Clinical data from 469 inoperable 
NSCLC patients, treated with curative intent with 
chemoradiation (CRT) or radiotherapy (RT) alone were 
collected. The esophagus was delineated using the external 
esophageal contour from the cricoid cartilage to the GE 
junction. A Bayesian network model was developed to predict 
severe acute dysphagia (≥ Grade 3 according to the 
CTCAEv3.0). Data was weighted in proportion to how recent 
the RT took place. The model utilized gender, WHO 
performance status, mean esophageal dose, maximum 
esophageal dose and overall treatment time to make 
predictions. The model was trained on data from 363 
patients. The model’s performance was assessed on data 
from the 106 most recently treated patients and expressed as 
the Area Under the Curve (AUC) of the Receiver Operating 
Characteristic (ROC). The maximum value of the AUC is 1.0; 
indicating a perfect prediction model. A value of 0.5 
indicates that patients are correctly classified in 50% of the 
cases, e.g., as good as chance. Comparison of ROC curves 
was done using the method described in Hanley and McNeil 
(1983). 
Results: Fifty-one patients (11%) developed acute severe 
dysphagia. The model was validated on a dataset of 106 
recently treated patients. The AUC of the model that weights 
data based on its novelty was 0.69 (95%CI, 0.59–0.77) versus 
an AUC of 0.64 (95%CI, 0.54–0.73) for the model that treats 
all data with equal importance. The ROC curves are 
significantly different (P < 0.05).  
 
 
Conclusions: An increase in classification performance is 
observed by weighting data in proportion to how recent the 
treatment has occurred. The Bayesian network could be used 
in clinical practice to more accurately predict patients at 
high risk of developing acute dysphagia. Furthermore, this 
study shows the potential of rapid learning health care 
systems to develop and update prediction models for 
personalized treatment of cancer patients. 
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Purpose/Objective: Hodgkin Lymphoma (HL) survivors have 
an increased risk of cardiovascular disease (CVD), lung cancer 
and breast cancer. We estimated the risk of developing CVD 
and secondary lung, breast, and thyroid cancer after 
radiotherapy (RT) delivered with deep inspiration breath-hold 
(DIBH) compared to free-breathing (FB) using 3D conformal 
RT (3DCRT) and intensity modulated RT (IMRT). The aim of 
this study was to determine which treatment modality best 
reduced the combined risk of life-threatening late effects in 
patients with mediastinal HL. 
Materials and Methods: Twenty two patients with early 
stage, mediastinal HL were eligible for the study and 
underwent a pre-chemotherapy PET/CT-scan in DIBH and in 
FB as well as a post-chemotherapy CT-scan in DIBH and in FB. 
All treatment plans delivered 30.6 Gy to initially involved 
nodes using either 3DCRT or IMRT on both the DIBH- and FB-
sets, with equal target coverage requirements. We reported 
the estimated dose to the heart, lung, female breasts, and 
thyroid as well as the heterogeneity index (HI=Dmax 
PTV/(prescription dose)) and conformity index (CI= V95% 
body/Volume PTV) for each plan. The excess risks were 
calculated using dose-response relationships from large series 
of HL survivors with long-term follow-up (CD, lung cancer and 
breast cancer) and from the Childhood Cancer Survivor Study 
(thyroid cancer). The 'life-years lost' (LYL) measure was used 
compare the risks of late effects on a common scale 
(considering age-at-exposure, life-expectancy, and prognosis 
of the different late effects). Results were analyzed using a 
repeated measures analysis of variance (rANOVA) with 
treatment technique as a categorical variable (3D-DIBH, 
IMRT-DIBH, 3D-FB or IMRT-FB). 
Results: DIBH lowered the dose to heart and lung regardless 
of delivery technique (p<0.001), cf. figure 1. The mean 
breast dose was increased with IMRT regardless of breathing 
technique. There was no difference in HI between the 4 
categories of plans (p=0.3), whereas IMRT plans were 
consistently more conformal than 3DCRT with a median CI of 
2.5, 2.7, 1.2, and 1.2 for 3D-FB, 3D-DIBH, IMRT-FB, and IMRT-
DIBH, respectively. The overall lowest risk estimates for CVD 
and lung cancer were seen with IMRT-DIBH and for breast 
cancer with 3D-DIBH (see table 1). DIBH provided the lowest 
total LYL (with a range of 0.1-1.2 years for 3D-DIBH and 0.1-
1.3 for IMRT-DIBH) and FB the highest (0.1-1.7 and 0.1-1.8 for 
3D-FB and IMRT-FB respectively). For both DIBH and FB, 
3DCRT vs. IMRT were not significantly different in post hoc 
tests for LYL. 
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Conclusions: DIBH lowered the estimated dose to heart and 
lung while IMRT increased the mean breast dose regardless of 
breathing technique. In average, LYL was lowest with DIBH 
and highest with FB. Overall in this cohort, 3D-DIBH resulted 
in the lowest estimated doses life-time excess risks, though 
combining IMRT and DIBH could be beneficial for a sub-group 
of patients. 
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Purpose/Objective: Tumour control probability (TCP) models 
may be useful for evaluation and optimisation of 
radiotherapy (RT), in particular in dose escalation/painting 
strategies. Most TCP models apply homogeneous values of the 
involved parameters such as the initial tumour cell density or 
the involved radiobiological parameters. However, functional 
imaging techniques may provide patient-specific information 
that could be taken advantage of in TCP modelling. Focusing 
on RT of prostate cancer, the aim of this study was to 
develop a method for individualising TCP models based on 
tumour cell density distributions estimated from magnetic 
resonance imaging-based apparent diffusion coefficient (ADC) 
maps. 
Materials and Methods: The TCP models were based on 
linear-quadratic cell survival curves, while also including 
terms such as treatment time (i.e. repopulation, with an 
effective doubling time of 28 days), cell repair (with a repair 
half time of 5 h) as well as a variation of the radiobiological 
parameters between sub-populations (SD of α and β of 15%). 
Using ADC maps in a series of 10 prostate cancer patients, 
the initial number of clonogens in each voxel (N0,i = ri·Vvoxel) 
was estimated using two different approaches for the 
relation between ADC values and cell density, a linear (LIN) 
and a sigmoid (SIGMOID) relation; each of the relations were 
used either in the index tumour or for the whole prostate 
(Table 1). The linear relation was derived from the results of 
Gibbs et al. 2009 while the SIGMOID relation modulated the 
cell density between two constant values, 1.9·105 cell/cm3 
(Walsh and van der Putten 2013) and 107 cell/cm3 (Søvik et 
al. 2007). TCP calculations were also performed using these 
two uniform densities for the whole prostate tissue. All TCP 
calculations were performed assuming an α/β = 1.93 Gy from 
a recent meta-analysis (Vogelius and Bentzen 2013) and α = 
0.18 Gy-1 (consistent with clinical outcomes in the same 
meta-analysis).  
Results:  
 
Overall, TCP curves based on ADC maps showed larger 
differences between individuals than those assuming a 
uniform cell density. Using the SIGMOID relation for the index 
lesion, the range of D50% (the dose required to reach 50% 
TCP) was 9.6 Gy, compared to 5.3 Gy using a constant density 
for the entire prostate of 107 cells/cm3 (Fig. 1). The TCP 
curves found using the SIGMOID relation for the whole 
prostate were very close to those found using a constant cell 
density of 107 cells/cm3. The two linear approaches gave 
lower TCP values (for the same dose) than either of these 
approaches.  
Conclusions: This study has showed how ADC maps can be 
used to estimate voxel cell density to allow for an 
individualised TCP model for use in RT of prostate cancer. 
The individualised, voxel-based cell density distributions 
resulted in TCP curves with a larger range in D50% compared 
with the TCP models based on uniform cell density 
distributions.  
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